Author

J. Eom

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

B. E. West· 1 shared B. Obeng· 1 shared C. T. Frangos· 1 shared D. Choi· 1 shared D. J. Wagner· 1 shared D. R. Smith· 1 shared J. A. Gosse· 1 shared J. Jeong· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

B. E. West

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Antimicrobial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase

B. Obeng, L. J. Bennett, B. E. West, D. J. Wagner, P. J. Fleming, M. N. Tasker, M. K. Lorenger, D. R. Smith, T. Systuk, S. M. Plummer, J. Eom, M. D. Paine, C. T. Frangos, M. P. Wilczek, J. K. Shim, , J. A. Gosse

This study shows that cetylpyridinium chloride inhibits mast cell function by disrupting tyrosine phosphorylation of Syk kinase and LAT, without affecting Lyn kinase.

bioRxiv · Jul 4, 2024 · PreprintPharmacology & Toxicology

Ex vivo therapeutic base and prime editing using chemically derived hepatic progenitors in a mouse model of tyrosinemia type 1

Y. Kim, J. Yu, S.-A. Hong, J. Eom, K. Jang, S.-N. Lee, J.-S. Woo, J. Jeong, S. Bae, D. Choi

This study corrects a disease-causing mutation in a mouse model of tyrosinemia type 1 using ex vivo base and prime editing with chemically derived hepatic progenitors, improving survival rates.

bioRxiv · Sep 14, 2020 · PreprintCell Biology